Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.

Gaidukov L, Viji RI, Yacobson S, Rosenblat M, Aviram M, Tawfik DS.

Biochemistry. 2010 Jan 26;49(3):532-8. doi: 10.1021/bi9013227.

PMID:
20025294
[PubMed - indexed for MEDLINE]
2.

High density lipoprotein structure-function and role in reverse cholesterol transport.

Lund-Katz S, Phillips MC.

Subcell Biochem. 2010;51:183-227. doi: 10.1007/978-90-481-8622-8_7. Review.

PMID:
20213545
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The effect of HDL mimetic peptide 4F on PON1.

Vakili L, Hama S, Kim JB, Tien D, Safarpoor S, Ly N, Vakili G, Hough G, Navab M.

Adv Exp Med Biol. 2010;660:167-72. doi: 10.1007/978-1-60761-350-3_15. Review.

PMID:
20221879
[PubMed - indexed for MEDLINE]
4.

The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function.

James RW, Deakin SP.

Adv Exp Med Biol. 2010;660:173-81. doi: 10.1007/978-1-60761-350-3_16. Review.

PMID:
20221880
[PubMed - indexed for MEDLINE]
5.

The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity.

James RW, Deakin SP.

Free Radic Biol Med. 2004 Dec 15;37(12):1986-94. Review.

PMID:
15544917
[PubMed - indexed for MEDLINE]
6.

Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer.

Zannis VI, Chroni A, Kypreos KE, Kan HY, Cesar TB, Zanni EE, Kardassis D.

Curr Opin Lipidol. 2004 Apr;15(2):151-66. Review.

PMID:
15017358
[PubMed - indexed for MEDLINE]
7.

Age-associated decrease of high-density lipoprotein-mediated reverse cholesterol transport activity.

Berrougui H, Khalil A.

Rejuvenation Res. 2009 Apr;12(2):117-26. doi: 10.1089/rej.2008.0840. Review.

PMID:
19405812
[PubMed - indexed for MEDLINE]
8.

Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.

Mackness B, Mackness M.

Adv Exp Med Biol. 2010;660:143-51. doi: 10.1007/978-1-60761-350-3_13. Review.

PMID:
20221877
[PubMed - indexed for MEDLINE]
9.

[Advances in apolipoprotein A- I and it's anti-atherosclerosis properties].

Li M, Liu ZM.

Sheng Wu Gong Cheng Xue Bao. 2003 Jul;19(4):387-91. Review. Chinese.

PMID:
15969051
[PubMed - indexed for MEDLINE]
10.

Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.

Tavori H, Vaya J, Aviram M.

Adv Exp Med Biol. 2010;660:99-111. doi: 10.1007/978-1-60761-350-3_10. Review.

PMID:
20221874
[PubMed - indexed for MEDLINE]
11.

The paraoxonase 1, 2 and 3 in humans.

Rajkovic MG, Rumora L, Barisic K.

Biochem Med (Zagreb). 2011;21(2):122-30. Review.

PMID:
22135851
[PubMed - indexed for MEDLINE]
Free Article
12.

Effect of dietary lipids on paraoxonase-1 activity and gene expression.

Ferretti G, Bacchetti T.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):88-94. doi: 10.1016/j.numecd.2011.08.011. Epub 2011 Nov 25. Review.

PMID:
22118836
[PubMed - indexed for MEDLINE]
13.

Paraoxonase, a cardioprotective enzyme: continuing issues.

Getz GS, Reardon CA.

Curr Opin Lipidol. 2004 Jun;15(3):261-7. Review.

PMID:
15166781
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk